Opening book details…
Can I read Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias on EtoBox?
Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias by Elena Tsoy; Renaud La Joie; Lawren VandeVrede; Julio C. Rojas; Claire Yballa; Brandon Chan; Argentina Lario Lago; Anne‐Marie Rodriguez; Collette A. Goode; Sabrina J. Erlhoff; Boon Lead Tee; Charles Windon; Serggio Lanata; Joel H. Kramer; Bruce L. Miller; Peggye Dilworth‐Anderson; Adam L. Boxer; Gil D. Rabinovici; Katherine L. Possin is a Medicine article available to read on EtoBox.
What is Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias about?
## Abstract ## INTRODUCTION With emergence of disease‐modifying therapies, efficient diagnostic pathways are critically needed to identify treatment candidates, evaluate disease severity, and support prognosis. A combination of plasma biomarkers and brief digital cognitive assessments could provide a scalable alternative to current diagnostic work‐up. ## METHODS We examined the accuracy of plasma biomarkers and a 10‐minute supervised tablet‐based cognitive assessment (Tablet‐based Cognitive Assessment Tool Brain Health Assessment [TabCAT‐BHA]) in predicting amyloid β positive (Aβ+) status on positron emission tomography (PET), concurrent disease severity, and functional decline in 309 older adults with subjective cognitive impairment (__n__ = 49), mild cognitive impairment (__n__ = 159), and dementia (__n__ = 101). ## RESULTS Combination of plasma pTau181, Aβ42/40, neurofilament light (NfL), and TabCAT‐BHA was optimal for predicting Aβ‐PET positivity (AUC = 0.962). Whereas NfL and TabCAT‐BHA optimally predicted concurrent disease severity, combining these with pTau181 and glial fibrillary acidic protein was most accurate in predicting functional decline. ## DISCUSSION Combinations
Who reads Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Elena Tsoy; Renaud La Joie; Lawren VandeVrede; Julio C. Rojas; Claire Yballa; Brandon Chan; Argentina Lario Lago; Anne‐Marie Rodriguez; Collette A. Goode; Sabrina J. Erlhoff; Boon Lead Tee; Charles Windon; Serggio Lanata; Joel H. Kramer; Bruce L. Miller; Peggye Dilworth‐Anderson; Adam L. Boxer; Gil D. Rabinovici; Katherine L. Possin
- Publisher
- John Wiley and Sons Inc.
- Published
- 2024
- Language
- EN
- Field
- Medicine (Health Sciences)